Table 1B.
Cohort I
| |||||
---|---|---|---|---|---|
Total | Serous | Clear cell | Endometrioid | Mucinous | |
Total | 126 | 63 | 13 | 36 | 14 |
Stage I | 72 | 22 | 12 | 24 | 14 |
Stage II | 0 | 0 | 0 | 0 | 0 |
Stage III | 36 | 28 | 1 | 7 | 0 |
Stage IV | 18 | 13 | 0 | 5 | 0 |
Cohort II | |||||
Total | Serous | Clear cell | Endometrioid | Mucinous | |
Total | 200 | 159 | 8 | 2 | 31 |
Stage I | 39 | 14 | 3 | 2 | 20 |
Stage II | 17 | 15 | 0 | 0 | 2 |
Stage III | 129 | 116 | 4 | 0 | 9 |
Stage IV | 15 | 14 | 1 | 0 | 0 |
Total | 200 | 159 | 8 | 2 | 31 |
Borderline | 43 | 25 | 1 | 0 | 17 |
High Grade | 144 | 129 | 7 | 2 | 6 |
Low Grade | 13 | 5 | 0 | 0 | 8 |